Drug intelligence / Profile preview

DWP431

Development stage
Preclinical
Lead developer
Daewoong Pharmaceutical
Modality
Recombinant Proteins and Enzymes
Administration
Implant
01

Overview

DWP431 is a biopharmaceutical candidate consisting of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2), developed by Daewoong Pharmaceutical in collaboration with Great Bear Pharmaceutical. It is specifically designed for use in spinal fusion procedures to promote bone growth and stabilization. As an osteoinductive protein, DWP431 stimulates the recruitment and differentiation of mesenchymal stem cells into bone-forming osteoblasts. The product is typically delivered via a carrier, such as a hydroxyapatite or collagen scaffold, to the site of surgery. DWP431 is the development code for the version of Daewoong's BMP-2 technology (marketed as Novosis in South Korea) being advanced for clinical use and regulatory approval in the United States and Japan.

Brand names
Novosis
Other names
recombinant human Bone Morphogenetic Protein-2rhBMP-2rhBMP2rhBMP 2DWP401DWP-401DWP 401
02

Targets

BMPR1ABMPR1BBMPR2 (Bone morphogenetic protein receptor type II)

Beyond the preview

Go deeper on DWP431.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DWP431.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call